StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
5556
This month
109
This week
27
This year
494
Today
12
Yesterday
22
Publishing Date
2024 - 04 - 24
12
2024 - 03 - 04
14
2023 - 12 - 21
13
2023 - 12 - 12
13
2023 - 12 - 06
14
2023 - 11 - 27
13
2023 - 10 - 23
12
2023 - 10 - 18
13
2023 - 10 - 16
16
2023 - 10 - 04
14
2023 - 09 - 26
18
2023 - 09 - 20
12
2023 - 09 - 07
15
2023 - 06 - 26
13
2023 - 06 - 15
12
2023 - 04 - 27
12
2023 - 04 - 25
15
2023 - 04 - 17
15
2023 - 03 - 27
12
2023 - 02 - 23
13
2023 - 01 - 30
16
2023 - 01 - 26
12
2023 - 01 - 25
15
2023 - 01 - 04
12
2022 - 11 - 17
13
2022 - 10 - 12
14
2022 - 10 - 06
14
2022 - 09 - 14
14
2022 - 09 - 13
12
2022 - 08 - 22
13
2022 - 05 - 24
12
2022 - 05 - 17
13
2022 - 05 - 03
14
2022 - 03 - 28
14
2022 - 01 - 24
18
2021 - 12 - 22
12
2021 - 12 - 13
15
2021 - 12 - 09
12
2021 - 12 - 06
13
2021 - 11 - 01
12
2021 - 10 - 18
15
2021 - 10 - 14
12
2021 - 10 - 12
12
2021 - 10 - 07
12
2021 - 10 - 04
12
2021 - 09 - 07
12
2021 - 06 - 29
12
2021 - 06 - 25
13
2021 - 06 - 23
14
2021 - 06 - 21
13
2021 - 06 - 11
11
2021 - 06 - 04
13
2021 - 06 - 03
12
2021 - 06 - 01
14
2021 - 05 - 21
15
2021 - 05 - 03
14
2021 - 04 - 14
11
2021 - 03 - 22
13
2021 - 01 - 04
11
2020 - 12 - 21
12
Sector
Administrative and support and waste management and remediation services
3
Commercial services
42
Communications
91
Consumer durables
4
Consumer non-durables
18
Consumer services
11
Distribution services
20
Electronic technology
17
Energy minerals
2
Finance
121
Finance and insurance
10
Health care and social assistance
15
Health services
58
Health technology
4220
Industrial services
41
Information
7
Manufacturing
369
Mining, quarrying, and oil and gas extraction
7
N/a
172
Non-energy minerals
10
Process industries
118
Producer manufacturing
97
Professional, scientific, and technical services
131
Real estate and rental and leasing
3
Retail trade
8
Technology services
42
Transportation
10
Transportation and warehousing
1
Utilities
15
Wholesale trade
9
Tags
Alliances
99
Als
91
Application
382
Approval
374
Biotech
87
Biotech-bay
113
Biotech-beach
125
Cancer
626
Cell
88
Chmp
97
Clearance
141
Clinical-trials-phase-ii
205
Clinical-trials-phase-iii
141
Collaboration
98
Covid
177
Covid-19
139
Designation
430
Diabetes
94
Disease
532
Drug
578
Enroll
86
Europe
181
Events
96
Fast track designation
107
Fda
949
Fda-approvals
114
Food
88
Genetown
149
Global
214
Granted
155
Growth
158
Health
111
License
125
Market
359
Meeting
105
N/a
3142
New drug
97
Patent
147
Pharm-country
175
Pharma
93
Pharmaceuticals
250
Phase 1
179
Phase 2
249
Phase 2b
114
Phase 3
195
Positive
432
Potential
275
Preclinical
108
Report
154
Research
545
Results
242
Review
92
Study
327
Submission
88
Therapeutics
553
Therapy
349
Topline
108
Treatment
5321
Trial
860
Water
93
Entities
3m company
21
Abbott laboratories
62
Abbvie inc.
121
Accuray incorporated
21
Adamis pharmaceuticals corporation
19
Adial pharmaceuticals, inc
22
Alnylam pharmaceuticals, inc.
38
Amgen inc.
47
Arcutis biotherapeutics, inc.
25
Arrowhead pharmaceuticals, inc.
22
Astellas pharma inc
52
Astrazeneca plc
52
Bausch health companies inc.
36
Biogen inc.
42
Biohaven pharmaceutical holding company ltd.
19
Bioxcel therapeutics, inc.
20
Boston scientific corporation
21
Brainsway ltd.
41
Bridgebio pharma, inc.
20
Bristol-myers squibb company
94
Cns pharmaceuticals, inc.
26
Coherus biosciences, inc.
28
Compass pathways plc
20
Ecolab inc.
47
Eli lilly and company
180
Fortress biotech, inc.
27
Gilead sciences, inc.
50
Glaxosmithkline plc
103
Hoth therapeutics, inc.
24
Incyte corporation
77
Intellia therapeutics, inc.
32
Jazz pharmaceuticals plc
20
Johnson & johnson
211
Karyopharm therapeutics inc.
33
Koninklijke philips n.v.
21
Medicinova, inc.
24
Medtronic plc
46
Merck & company, inc.
66
Moleculin biotech, inc.
28
Novartis ag
145
Novo nordisk a/s
37
Nrx pharmaceuticals inc
20
Orange
87
Perrigo company
23
Pfizer, inc.
75
Reata pharmaceuticals, inc.
28
Regeneron pharmaceuticals, inc.
58
Regenxbio inc.
25
Sanofi
299
Sorrento therapeutics, inc.
37
Takeda pharmaceutical company limited
55
Teleflex incorporated
21
Teva pharmaceutical industries ltd
79
Tg therapeutics, inc.
24
Tonix pharmaceuticals holding corp.
32
Ultragenyx pharmaceutical inc.
25
Verrica pharmaceuticals inc.
23
Vertex pharmaceuticals incorporated
27
Viatris inc.
46
Xylem inc.
35
Symbols
ABBV
121
ABT
62
ADIL
22
ALNY
38
ALPMF
52
ALPMY
52
AMGN
47
ARAY
21
ARQT
25
ARWR
22
AZN
52
AZNCF
44
BBIO
20
BHC
36
BIIB
42
BMY
94
BSX
21
BTAI
20
BWAY
41
CHRS
28
CNSP
26
ECL
47
FBIO
27
FNCTF
87
GILD
50
GLAXF
78
GSK
102
HOTH
24
INCY
77
JNJ
211
KPTI
33
LLY
180
MBRX
28
MDT
46
MMM
21
MNOV
24
MRK
66
NTLA
32
NVO
37
NVS
145
NVSEF
121
PFE
75
PHG
21
PRGO
23
RARE
25
REGN
58
RETA
28
RGNX
25
SNY
299
SNYNF
251
SRNE
37
TAK
55
TEVJF
79
TFX
21
TGTX
24
TNXP
32
VRCA
23
VRTX
27
VTRS
46
XYL
35
Exchanges
Amex
115
Nasdaq
4629
Nyse
1350
Crawled Date
2024 - 04 - 24
14
2024 - 03 - 19
12
2024 - 03 - 05
12
2024 - 03 - 04
13
2023 - 12 - 12
13
2023 - 12 - 06
15
2023 - 11 - 27
14
2023 - 10 - 23
12
2023 - 10 - 18
13
2023 - 10 - 16
16
2023 - 10 - 04
14
2023 - 09 - 26
18
2023 - 09 - 25
12
2023 - 09 - 20
12
2023 - 09 - 13
13
2023 - 09 - 07
15
2023 - 06 - 26
13
2023 - 06 - 15
12
2023 - 04 - 27
13
2023 - 04 - 25
13
2023 - 04 - 17
15
2023 - 03 - 27
12
2023 - 02 - 23
12
2023 - 01 - 30
16
2023 - 01 - 25
16
2023 - 01 - 04
13
2022 - 11 - 17
14
2022 - 10 - 12
14
2022 - 10 - 06
14
2022 - 09 - 15
12
2022 - 09 - 14
15
2022 - 08 - 22
13
2022 - 05 - 17
13
2022 - 05 - 03
13
2022 - 03 - 28
14
2022 - 01 - 24
16
2021 - 12 - 13
15
2021 - 12 - 09
12
2021 - 12 - 06
14
2021 - 11 - 01
12
2021 - 10 - 18
15
2021 - 10 - 14
12
2021 - 10 - 12
12
2021 - 10 - 07
13
2021 - 10 - 04
12
2021 - 09 - 07
12
2021 - 06 - 29
12
2021 - 06 - 25
13
2021 - 06 - 23
14
2021 - 06 - 21
13
2021 - 06 - 04
13
2021 - 06 - 03
12
2021 - 06 - 01
14
2021 - 05 - 21
15
2021 - 05 - 03
13
2021 - 03 - 22
14
2020 - 12 - 21
14
2020 - 12 - 15
16
2020 - 12 - 02
12
2020 - 12 - 01
18
Crawled Time
00:00
131
00:01
3
00:20
24
01:00
97
02:00
38
03:00
26
04:00
19
04:20
16
05:00
30
06:00
66
07:00
68
08:00
67
08:20
6
09:00
77
09:08
3
10:00
64
10:16
6
11:00
314
11:01
3
11:03
3
12:00
761
12:01
12
12:03
16
12:07
4
12:11
3
12:15
67
12:20
136
12:30
119
13:00
629
13:01
3
13:02
4
13:03
14
13:05
4
13:15
41
13:20
153
13:30
112
14:00
448
14:01
12
14:02
4
14:03
6
14:15
22
14:20
60
14:30
74
15:00
233
15:01
7
15:15
9
15:20
37
15:30
56
16:00
156
16:20
32
17:00
158
18:00
132
19:00
138
20:00
148
20:20
17
21:00
189
22:00
185
22:01
5
22:15
7
23:00
166
Source
adialpharma.com
1
alteritytherapeutics.com
6
alzamend.com
1
apyxmedical.com
1
arcutis.com
2
brainsway.com
3
bridgebio.com
3
brightmindsbio.com
1
broadstone.com
1
canohealth.com
1
compasspathways.com
1
investor.alkermes.com
7
investor.aveooncology.com
4
investors.biomarin.com
5
investors.phiopharma.com
2
ir.ateapharma.com
5
ir.auriniapharma.com
6
ir.hoththerapeutics.com
3
ir.kalvista.com
6
ir.pulmatrix.com
3
ir.vtvtherapeutics.com
3
jaguarhealth.gcs-web.com
15
nanthealth.com
3
ocutx.gcs-web.com
3
renovorx.com
10
spacfeed.com
9
www.4dpharmaplc.com
9
www.akerotx.com
3
www.alnylam.com
4
www.ameresco.com
2
www.anaptysbio.com
4
www.anavex.com
2
www.beyondspringpharma.com
2
www.biolase.com
2
www.biospace.com
2364
www.brainsway.com
27
www.clarivate.com
4
www.crinetics.com
3
www.enochianbio.com
2
www.fda.gov
6
www.globenewswire.com
1705
www.hepionpharma.com
2
www.igcinc.us
2
www.inovio.com
2
www.jupiterwellnessinc.com
2
www.kempharm.com
2
www.limoneira.com
3
www.marronebio.com
2
www.myriad.com
2
www.nanthealth.com
5
www.phiopharma.com
2
www.precisionbiosciences.com
2
www.prnewswire.com
1214
www.progyny.com
12
www.rubiustx.com
2
www.stagindustrial.com
2
www.sutrobio.com
3
www.uhsinc.com
2
www.vbivaccines.com
3
www.vynetherapeutics.com
3
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
treatment
published :
Previous years
save search
Precigen to Present Late-breaking Abstract for Pivotal Phase 2 Study Data for PRGN-2012 AdenoVerse Immunotherapy for the Treatment of Patients with Recurrent Respiratory Papillomatosis at the 2024 ASCO Annual Meeting
Published:
2024-04-24
(Crawled : 19:00)
- biospace.com/
PGEN
|
$1.42
1.43%
1.41%
560K
|
Health Technology
|
1.43%
|
O:
0.0%
H:
2.14%
C:
1.43%
prgn-2012
respiratory
asco
treatment
immunotherapy
for
meeting
study
Regeneron to Showcase Progress in Advancing Novel Investigational Treatment Approaches for a Broad Range of Solid Tumors and Blood Cancers at ASCO
Published:
2024-04-24
(Crawled : 14:00)
- globenewswire.com
SNYNF
|
News
|
$94.25
-2.18%
480
|
Health Technology
|
-0.27%
|
O:
0.8%
H:
0.0%
C:
-1.05%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
0.82%
|
O:
0.82%
H:
0.0%
C:
0.0%
REGN
|
News
|
$906.55
-0.09%
-0.08%
370K
|
Health Technology
|
-0.09%
|
O:
-0.05%
H:
0.97%
C:
-0.04%
asco
tumors
treatment
blood
for
Amneal Announces U.S. FDA Approval of Over-the-Counter Naloxone Hydrochloride Nasal Spray for Emergency Treatment of an Opioid Overdose
Published:
2024-04-24
(Crawled : 14:00)
- biospace.com/
AMRX
|
$6.07
12.41%
11.04%
3.1M
|
Health Technology
|
12.04%
|
O:
6.67%
H:
6.08%
C:
5.03%
fda
opioid
approval
treatment
for
spray
Arrowhead Pharmaceuticals Initiates Phase 1/2a Study of ARO-CFB for Treatment of Complement Mediated Kidney Disease
Published:
2024-04-24
(Crawled : 14:00)
- biospace.com/
ARWR
|
$23.285
-2.08%
-2.13%
810K
|
Health Technology
|
-2.06%
|
O:
-0.17%
H:
0.08%
C:
-1.9%
disease
kidney
treatment
pharmaceuticals
for
study
United Kingdom’s MHRA Approves YORVIPATH® (palopegteriparatide) in Great Britain for the Treatment of Adults with Chronic Hypoparathyroidism
Published:
2024-04-24
(Crawled : 13:00)
- globenewswire.com
ASND
|
$143.14
-1.17%
-1.18%
230K
|
Health Technology
|
-1.14%
|
O:
-0.57%
H:
1.67%
C:
-0.57%
yorvipath
treatment
for
Innoviva Specialty Therapeutics’ Positive Phase 3 Oral Zoliflodacin Data for the Treatment of Uncomplicated Gonorrhea Announced at ESCMID Global 2024
Published:
2024-04-24
(Crawled : 12:00)
- biospace.com/
INVA
|
$15.15
-0.13%
-0.13%
420K
|
Health Technology
|
0.9%
|
O:
1.03%
H:
0.72%
C:
-0.13%
positive
treatment
global
for
atai Life Sciences Announces Dosing of First Patient in Part 2 of Beckley Psytech’s Phase 2a Study Exploring BPL-003 Adjunctive to SSRIs in Patients with Treatment Resistant Depression
Published:
2024-04-24
(Crawled : 11:00)
- globenewswire.com
ATAI
|
$1.875
-4.82%
-5.07%
830K
|
Manufacturing
|
-5.56%
|
O:
-1.01%
H:
0.0%
C:
-4.59%
bpl-003
first
life
depression
treatment
sciences
study
Alkermes Announces Initiation of Vibrance-1 Phase 2 Study Evaluating ALKS 2680 for the Treatment of Narcolepsy Type 1
Published:
2024-04-24
(Crawled : 11:00)
- prnewswire.com
ALKS
|
$24.66
1.65%
1.62%
1.7M
|
Health Technology
|
2.05%
|
O:
0.43%
H:
2.27%
C:
1.61%
narcolepsy
treatment
for
study
HOOKIPA Pharma Announces FDA Clearance of its Investigational New Drug Application for HB-700 for the Treatment of KRAS-Mutated Cancers
Published:
2024-04-24
(Crawled : 11:00)
- globenewswire.com
HOOK
|
$0.843
10.2%
9.25%
10M
|
Health Technology
|
15.02%
|
O:
10.96%
H:
6.1%
C:
3.66%
hb-700
fda
pharma
drug
treatment
clearance
for
application
Travere Therapeutics and CSL Vifor Announce European Commission Approves FILSPARI® (sparsentan) for the treatment of IgA Nephropathy
Published:
2024-04-24
(Crawled : 11:00)
- globenewswire.com
TVTX
|
$5.46
-4.88%
-5.13%
2M
|
Health Technology
|
-7.78%
|
O:
-2.2%
H:
0.0%
C:
-5.71%
filspari
nephropathy
treatment
for
therapeutics
CSL Vifor and Travere Therapeutics Announce European Commission approves FILSPARI® (sparsentan) for the treatment of IgA Nephropathy
Published:
2024-04-24
(Crawled : 07:00)
- prnewswire.com
AKBA
|
$1.36
-0.73%
-0.74%
1.5M
|
Health Technology
|
0.0%
|
O:
0.0%
H:
2.19%
C:
0.0%
TVTX
|
$5.46
-4.88%
-5.13%
2M
|
Health Technology
|
-7.78%
|
O:
-2.2%
H:
0.0%
C:
-5.71%
filspari
nephropathy
treatment
for
therapeutics
Novartis and Medicines for Malaria Venture announce positive efficacy and safety data for a novel treatment for babies <5 kg with malaria
Published:
2024-04-24
(Crawled : 05:00)
- globenewswire.com
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
-0.52%
|
O:
-0.36%
H:
0.05%
C:
-0.15%
malaria
positive
treatment
for
novartis
Curio Digital Therapeutics Inc. Announces the U.S. Food and Drug Administration (FDA) Clearance of MamaLift Plus™, the First Prescription Digital Therapeutic Authorized for the Treatment of Postpartum Depression (PPD)
Published:
2024-04-23
(Crawled : 00:00)
- biospace.com/
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
2.53%
|
O:
1.7%
H:
0.0%
C:
0.0%
first
drug
authorized
food
depression
treatment
clearance
for
therapeutics
Astellas' XTANDI™ (Enzalutamide) Granted European Commission Approval for Use in Additional Recurrent Early Prostate Cancer Treatment Setting
Published:
2024-04-23
(Crawled : 00:00)
- prnewswire.com
ALPMY
|
News
|
$9.49
-1.11%
480K
|
Manufacturing
|
-0.21%
|
O:
-1.05%
H:
0.85%
C:
0.85%
TAK
|
News
|
$13.23
-1.12%
0.0%
920K
|
Health Technology
|
-0.86%
|
O:
-0.19%
H:
0.08%
C:
-0.68%
granted
approval
cancer
treatment
for
Response Pharmaceuticals’ Drug Candidate for the Treatment of Antipsychotic-Induced Weight Gain (AIWG) Achieves Primary Endpoint in Phase 1b Clinical Trial
Published:
2024-04-23
(Crawled : 14:30)
- biospace.com/
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
2.53%
|
O:
1.7%
H:
0.0%
C:
0.0%
drug
candidate
treatment
for
trial
response
BiomX to Present Data from Phase 1b/2a Study of BX004 for the Treatment of Cystic Fibrosis Patients
Published:
2024-04-23
(Crawled : 13:30)
- biospace.com/
PHGE
|
$0.3274
-5.51%
3.82%
130K
|
Health Technology
|
12.58%
|
O:
9.27%
H:
6.06%
C:
6.06%
bx004
treatment
fibrosis
for
study
FDA Rejects Abeona’s Gene Therapy, Approves ImmunityBio’s Bladder Cancer Treatment
Published:
2024-04-23
(Crawled : 13:30)
- biospace.com/
PRGO
|
$31.23
2.43%
0.0%
960K
|
Health Technology
|
3.89%
|
O:
0.13%
H:
1.89%
C:
1.3%
JNJ
|
News
|
$148.53
-0.69%
-0.14%
9.6M
|
Health Technology
|
-0.13%
|
O:
0.89%
H:
0.0%
C:
0.0%
ABT
|
News
|
$106.89
-0.65%
-0.22%
5.1M
|
Health Technology
|
-0.17%
|
O:
0.56%
H:
0.41%
C:
-0.07%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
2.53%
|
O:
1.7%
H:
0.0%
C:
0.0%
fda
bladder
cancer
treatment
PROCEPT BioRobotics Announces 12 Scientific Research Presentations on Aquablation Therapy for the Treatment of Benign Prostatic Hyperplasia at the 2024 AUA Annual Meeting
Published:
2024-04-23
(Crawled : 12:00)
- globenewswire.com
PRCT
A
|
$52.51
-2.31%
-2.36%
520K
|
Manufacturing
|
3.65%
|
O:
0.91%
H:
6.09%
C:
5.21%
treatment
aquablation
research
biorobotics
for
meeting
therapy
BiomX to Present Data from Phase 1b/2a Study of BX004 for the Treatment of Cystic Fibrosis Patients with Chronic Pulmonary Infections at the 34th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024)
Published:
2024-04-23
(Crawled : 12:00)
- globenewswire.com
PHGE
|
$0.3274
-5.51%
3.82%
130K
|
Health Technology
|
12.58%
|
O:
9.27%
H:
6.06%
C:
6.06%
bx004
congress
treatment
fibrosis
for
infections
study
Silo Pharma Announces Positive Results for Intranasal PTSD Treatment
Published:
2024-04-23
(Crawled : 12:00)
- globenewswire.com
SILO
|
$1.9
6.74%
6.32%
380K
|
Finance and Insurance
|
-4.08%
|
O:
9.18%
H:
0.47%
C:
-16.82%
pharma
positive
treatment
for
results
← Previous
1
2
3
4
5
6
7
8
9
…
277
278
Next →
Gainers vs Losers
62%
38%
Top 10 Gainers
CSSE
4
|
$0.4323
183.85%
64.77%
220M
|
Consumer Services
BOF
|
$1.99
70.09%
41.21%
110M
|
ILAG
|
$0.51
6.03%
40.62%
1.7M
|
LICN
|
$0.941
68.04%
40.49%
15M
|
AMST
|
$3.31
65.5%
39.58%
70M
|
Technology Services
MTC
|
$3.615
61.38%
38.04%
9.3M
|
Technology Services
WIMI
|
$1.15
58.53%
36.92%
19M
|
Technology Services
AIH
|
$0.45
12.5%
30.92%
320K
|
Health Services
MULN
|
News
|
$3.78
38.46%
27.78%
13M
|
Information
RILY
|
$29.86
37.48%
27.26%
12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.